Kaiser Permanente-Capitol Hill Medical Center — Washington D.C., District of Columbia

Kaiser Permanente-Capitol Hill Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20002.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Kaiser Permanente-Capitol Hill Medical Center has participated in 48 clinical trials with 35 currently active.

Therapeutic areas: Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente-Capitol Hill Medical Center?

Kaiser Permanente-Capitol Hill Medical Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente-Capitol Hill Medical Center conducted?

Kaiser Permanente-Capitol Hill Medical Center has 48 clinical trials on record, with 35 currently active. Their work covers Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.

Is Kaiser Permanente-Capitol Hill Medical Center accredited by Crixeo Health?

Yes — Kaiser Permanente-Capitol Hill Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kaiser Permanente-Capitol Hill Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.